Becton Dickinson & Co (BDX): Capital Expenditures
$760.00M
Year ended 2025-09-30
-7.9%
3-year compound annual growth
-0.2%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $760.00M | +4.8% | 2025-11-25, From 2024-10-01 |
| 2024-09-30 | $725.00M | -17.0% | 2025-11-25, From 2023-10-01 |
| 2023-09-30 | $874.00M | -10.2% | 2025-11-25, From 2022-10-01 |
| 2022-09-30 | $973.00M | -18.5% | 2024-11-27, From 2021-10-01 |
| 2021-09-30 | $1.19B | +55.3% | 2023-11-21, From 2020-10-01 |
| 2020-09-30 | $769.00M | n/c | 2022-11-22, From 2019-10-01 |
| 2019-09-30 | $957.00M | +6.9% | 2021-11-24, From 2018-10-01 |
| 2018-09-30 | $895.00M | +23.1% | 2020-11-25, From 2017-10-01 |
| 2017-09-30 | $727.00M | +4.9% | 2019-11-27, From 2016-10-01 |
| 2016-09-30 | $693.00M | +16.3% | 2018-11-21, From 2015-10-01 |
| 2015-09-30 | $596.00M | +0.7% | 2017-11-22, From 2014-10-01 |
| 2014-09-30 | $592.00M | +13.4% | 2016-11-23, From 2013-10-01 |
| 2013-09-30 | $522.00M | +7.2% | 2015-11-25, From 2012-10-01 |
| 2012-09-30 | $487.00M | -4.3% | 2014-11-26, From 2011-10-01 |
| 2011-09-30 | $509.00M | -4.1% | 2013-11-27, From 2010-10-01 |
| 2010-09-30 | $530.97M | n/c | 2012-11-21, From 2009-10-01 |
| 2009-09-30 | $585.20M | -1.8% | 2011-11-23, From 2008-10-01 |
| 2008-09-30 | $595.81M | +7.1% | 2010-11-24, From 2007-10-01 |
| 2007-09-30 | $556.29M | n/a | 2010-01-21, From 2006-10-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Becton Dickinson & Co (BDX) | 2025-09-30 | $760.00M | +4.8% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $876.00M | +10.9% |
| 3M Co (MMM) | 2025-12-31 | $910.00M | -22.9% |
| Stryker Corp (SYK) | 2025-12-31 | $761.00M | +0.8% |
| Medline Inc. (MDLN) | 2025-12-31 | $447.00M | +26.3% |
| Baxter International Inc (BAX) | 2025-12-31 | $513.00M | +15.0% |
| Solventum Corp (SOLV) | 2025-12-31 | $379.00M | -0.3% |
| ResMed Inc (RMD) | 2026-06-30 | $156.28M | +73.9% |
| Dexcom Inc (DXCM) | 2025-12-31 | $363.50M | +1.3% |
Compare BDX, BSX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗